Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Pharmaust Limited ( (AU:NUZ) ) is now available.
Neurizon Therapeutics Limited, a company focused on neurodegenerative diseases, presented at their AGM with insights into their future strategies and expectations. The presentation highlighted the company’s intentions and plans, though it noted that these are subject to risks and uncertainties, which may impact the actual outcomes. Stakeholders are advised to consider these factors when evaluating the company’s future performance.
The most recent analyst rating on (AU:NUZ) stock is a Buy with a A$0.56 price target. To see the full list of analyst forecasts on Pharmaust Limited stock, see the AU:NUZ Stock Forecast page.
More about Pharmaust Limited
Average Trading Volume: 778,681
Technical Sentiment Signal: Sell
Current Market Cap: A$58.82M
For a thorough assessment of NUZ stock, go to TipRanks’ Stock Analysis page.